Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

7 results
Display

Can Artemisinin Be a Game Changer Even as an Antiarrhythmic Drug?

Hwang J

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
To Take or Not to Take: The Dilemma With Marginal Donor Heart?

Park JJ

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Leadless Pacemaker Implantation in Renal Dialysis Patient With No Vascular Access

Afendoulis D, Voutas P, Papagiannis N, Moutafi M, Sitaras P, Maratsos A, Sideris S, Kartalis A

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment

Youn JC, Kim D, Cho JY, Cho DH, Park SM, Jung MH, Hyun J, Cho HJ, Park SM, Choi JO, Chung WJ, Yoo BS, Kang SM, on behalf of Committee of Clinical Practice Guidelines, Korean Society of Heart Failure

The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evidencebased recommendations for the management of patients with heart failure (HF). After the first introduction of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Definition and Diagnosis

Cho JY, Cho DH, Youn JC, Kim D, Park SM, Jung MH, Hyun J, Choi J, Cho HJ, Park SM, Choi JO, Chung WJ, Yoo BS, Kang SM, on behalf of Committee of Clinical Practice Guidelines, Korean Society of Heart Failure

The Korean Society of Heart Failure guidelines aim to provide physicians with evidence-based recommendations for diagnosing and managing patients with heart failure (HF). In Korea, the prevalence of HF has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiarrhythmic Effect of Artemisinin in an Ex-vivo Model of Brugada Syndrome Induced by NS5806

Jeong HK, Hong SN, Yoon N, Lee KH, Park HW, Cho JG

Background and Objectives: Brugada syndrome (BrS) is an inherited arrhythmia syndrome that presents as sudden cardiac death (SCD) without structural heart disease. One of the mechanisms of SCD has been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Outcomes of Marginal Donor Hearts: A Single Center Experience

Lee SY, Kim SH, Ju MH, Lim MH, Lee Ch, Je HG, Lim JH, Kim GY, Oh JS, Choi JH, Chon MK, Lee SH, Hwang KW, Kim JS, Park YH, Kim JH, Chun KJ

Background and Objectives: Although the shortage of donor is a common problem worldwide, a significant portion of unutilized hearts are classified as marginal donor (MD) hearts. However, research on the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr